XERS - Xeris Pharmaceuticals Q4 2021 Earnings Preview
Xeris Pharmaceuticals (NASDAQ:XERS) is scheduled to announce Q4 earnings results on Thursday, March 10th, before market open. The consensus EPS Estimate is -$0.16 (compared to -$11 a year ago) and the consensus Revenue Estimate is $18.99M (+167.8% Y/Y). Over the last 1 year, XERS has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time. Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward. Revenue estimates have seen 2 upward revisions and 0 downward.
For further details see:
Xeris Pharmaceuticals Q4 2021 Earnings Preview